Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Hematology | Immunology | Genetic Disease

Amyloidosis Clinical Trials

A listing of Amyloidosis medical research trials actively recruiting patient volunteers. Use the filters below to narrow your search results.

Filter by:

Phase:

Gender:

Age:

Location:

 

Receive E-mails About New Clinical Trials!

Sign up for our FREE service and we'll send you automatic email notifications as soon as a clinical trial is posted in the medical category you're interested in.


First 1 2 3 4 5 Last 

Arizona

Pfizer Investigational Site
Phoenix Arizona 85054

Patients are needed to participate in a clinical research study of None. Observational Study. to evaluate Transthyretin Mutations or Transthyretin Amyloidosis

Mayo Clinic Arizona
Scottsdale Arizona 85359

A clinical trial to evaluate treatments for patients with Relapsed or Refractory Systemic Light Chain Amyloidosis

California

Raffi Minasian MD a Medical Corporation
Glendale California 91204

A Phase 3 clinical study for patients with Amyloidosis

Clinical Trial Site
La Mesa California
Updated

A Phase 3 clinical study for patients with TTR-mediated Amyloidosis

Cedars-Sinai Medical Center
Los Angeles California 90048-18

A clinical trial to evaluate treatments for patients with Relapsed or Refractory Systemic Light Chain Amyloidosis

Clinical Trial Site
Orange California
Updated

A Phase 3 clinical study for patients with TTR-mediated Amyloidosis

Pfizer Investigational Site
Orange California 92868

Patients are needed to participate in a clinical research study of None. Observational Study. to evaluate Transthyretin Mutations or Transthyretin Amyloidosis

View More »

Stanford University Cancer Center
Palo Alto California 94305

A clinical trial to evaluate treatments using NEOD001 for patients with Primary Amyloidosis

Pfizer Investigational Site
San Francisco California 94117

Patients are needed to participate in a clinical research study of None. Observational Study. to evaluate Transthyretin Mutations or Transthyretin Amyloidosis

Pfizer Investigational Site
San Francisco California 94143

Patients are needed to participate in a clinical research study of None. Observational Study. to evaluate Transthyretin Mutations or Transthyretin Amyloidosis

Stanford Cancer Institute
Stanford California 94305

A Phase 1 clinical study for patients with Amyloidosis or Systemic Light-Chain Amyloidosis

Pfizer Investigational Site
Stanford California 94305

Patients are needed to participate in a clinical research study evaluating Tafamidis and Placebo for the treatment of Transthyretin (TTR) Amyloid Cardiomyopathy

Pfizer Investigational Site
Stanford California 94305-5406

Patients are needed to participate in a clinical research study of None. Observational Study. to evaluate Transthyretin Mutations or Transthyretin Amyloidosis

Sanguine Biosciences
Valencia California 91355

Patients are needed to participate in a clinical research study for the treatment of All Diagnosed Health Conditions

Colorado

Pfizer Investigational Site
Aurora Colorado 80045

Patients are needed to participate in a clinical research study of None. Observational Study. to evaluate Transthyretin Mutations or Transthyretin Amyloidosis

Clinical Trial Site
Denver Colorado
Updated

A Phase 3 clinical study for patients with TTR-mediated Amyloidosis

Florida

The Cleveland Clinic
Weston Florida 33331

A clinical trial to evaluate treatments for patients with Relapsed or Refractory Systemic Light Chain Amyloidosis

Georgia

Winship Cancer Institute of Emory University
Atlanta Georgia 30322

A Phase 1 clinical study for patients with Amyloidosis or Systemic Light-Chain Amyloidosis

Illinois

Sherman Health
Elgin Illinois 60123

ECOG E4A08: A Randomized Phase III Trial of Melphalan and Dexamethasone (MDex) versus Bortezomib, Melphalan, and Dexamethasone (BMDex) for Untreated Patients with Systemic Light-chain (AL) Amyloidosis Ineligible for Autologous Stem-cell Transplantation

View More »

University of Chicago
Chicago Illinois 60637

A clinical trial to evaluate treatments for patients with Relapsed or Refractory Systemic Light Chain Amyloidosis

Pfizer Investigational Site
Chicago Illinois 60611

Patients are needed to participate in a clinical research study evaluating Tafamidis and Placebo for the treatment of Transthyretin (TTR) Amyloid Cardiomyopathy

Pfizer Investigational Site
Chicago Illinois 60611

Patients are needed to participate in a clinical research study of None. Observational Study. to evaluate Transthyretin Mutations or Transthyretin Amyloidosis

Pfizer Investigational Site
Chicago Illinois 60637

Patients are needed to participate in a clinical research study of None. Observational Study. to evaluate Transthyretin Mutations or Transthyretin Amyloidosis

Pfizer Investigational Site
Oak Lawn Illinois 60453

Patients are needed to participate in a clinical research study evaluating Tafamidis and Placebo for the treatment of Transthyretin (TTR) Amyloid Cardiomyopathy

Pfizer Investigational Site
Oak Lawn Illinois 60453

Patients are needed to participate in a clinical research study of None. Observational Study. to evaluate Transthyretin Mutations or Transthyretin Amyloidosis

Indiana

IU Simon Cancer Center
Indianapolis Indiana 46202

A clinical trial to evaluate treatments for patients with Relapsed or Refractory Systemic Light Chain Amyloidosis

Indiana University
Indianapolis Indiana 46202

A Phase 3 clinical study for patients with Amyloidosis

Maryland

Pfizer Investigational Site
Baltimore Maryland 21287

Patients are needed to participate in a clinical research study evaluating Tafamidis and Placebo for the treatment of Transthyretin (TTR) Amyloid Cardiomyopathy

Pfizer Investigational Site
Baltimore Maryland 21201

Patients are needed to participate in a clinical research study evaluating Tafamidis and Placebo for the treatment of Transthyretin (TTR) Amyloid Cardiomyopathy

Pfizer Investigational Site
Baltimore Maryland 21201

Patients are needed to participate in a clinical research study of None. Observational Study. to evaluate Transthyretin Mutations or Transthyretin Amyloidosis

Pfizer Investigational Site
Baltimore Maryland 21205

Patients are needed to participate in a clinical research study of None. Observational Study. to evaluate Transthyretin Mutations or Transthyretin Amyloidosis

Massachusetts

Boston Medical Center
Boston Massachusetts 02118

A clinical research study of Pomalidomide and Dexamthasone for the treatment of AL Amyloidosis

Boston Medical Center HEM/ONCO
Boston Massachusetts 02118

A clinical trial to evaluate treatments for patients with Relapsed or Refractory Systemic Light Chain Amyloidosis

Tufts Medical Center
Boston Massachusetts 02111

A clinical trial to evaluate treatments for patients with Relapsed or Refractory Systemic Light Chain Amyloidosis

Boston University School of Medicine
Boston Massachusetts

A clinical trial to evaluate treatments using NEOD001 for patients with Primary Amyloidosis

Tufts Medical Center
Boston Massachusetts 02111

A clinical trial to evaluate treatments using NEOD001 for patients with Primary Amyloidosis

View More »

Boston Medical Center
Boston Massachusetts 02118

A Phase 3 clinical study for patients with Amyloidosis

Clinical Trial Site
Boston Massachusetts
Updated

Patients are needed to participate in a clinical research study evaluating ALN-TTR02 administered by intravenous (IV) infusion for the treatment of TTR-mediated Amyloidosis

Tufts Medical Center
Boston Massachusetts 02111

Patients are needed to participate in a clinical research study evaluating Bendamustine and Dexamethasone for the treatment of AL Amyloidosis

Boston Medical Center
Boston Massachusetts 02118

Patients are needed to participate in a clinical research study evaluating Bendamustine and Dexamethasone for the treatment of AL Amyloidosis

Clinical Trial Site
Boston Massachusetts 02155
Updated

Patients are needed to participate in a clinical research study of ALN-TTRSC for subcutaneous administration to evaluate TTR-mediated Amyloidosis

Pfizer Investigational Site
Boston Massachusetts 02215

Patients are needed to participate in a clinical research study of None. Observational Study. to evaluate Transthyretin Mutations or Transthyretin Amyloidosis

Michigan

Pfizer Investigational Site
Ann Arbor Michigan 48109

Patients are needed to participate in a clinical research study evaluating Tafamidis and Placebo for the treatment of Transthyretin (TTR) Amyloid Cardiomyopathy

Pfizer Investigational Site
Ann Arbor Michigan 48109

Patients are needed to participate in a clinical research study of None. Observational Study. to evaluate Transthyretin Mutations or Transthyretin Amyloidosis

Barbara Ann Karmanos Cancer Institute
Detroit Michigan 48201

A clinical trial to evaluate treatments for patients with Relapsed or Refractory Systemic Light Chain Amyloidosis

Karmanos Cancer Institute
Detroit Michigan 48201

A clinical trial to evaluate treatments using NEOD001 for patients with Primary Amyloidosis

Barbara Ann Karmanos Cancer Institute
Detroit Michigan 48201

Patients are needed to participate in a clinical research study evaluating Bendamustine and Dexamethasone for the treatment of AL Amyloidosis

Minnesota

Mayo Clinic
Rochester Minnesota 55905

A clinical trial to evaluate treatments for patients with Relapsed or Refractory Systemic Light Chain Amyloidosis

Mayo Clinic
Rochester Minnesota 55905

A clinical trial to evaluate treatments using NEOD001 for patients with Primary Amyloidosis

First 1 2 3 4 5 Last